Complex decision-making for BRCA1/2 carriers.
Matloff
E T
ET
Department of Genetics, Yale University School of Medicine, New Haven, CT 06195, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000235:genetics / Q000517:prevention & control; D003657:Decision Making; D005260:Female; D019398:Genes, BRCA1 / Q000235:genetics*; D005817:Genetic Counseling; D020022:Genetic Predisposition to Disease; D006579:Heterozygote; D006801:Humans; D007167:Immunotherapy; D009363:Neoplasm Proteins / Q000235:genetics*; D010051:Ovarian Neoplasms / Q000235:genetics / Q000517:prevention & control; D012307:Risk Factors; D014157:Transcription Factors / Q000235:genetics*
D000970:Antineoplastic Agents; D024682:BRCA2 Protein; D009363:Neoplasm Proteins; D014157:Transcription Factors